- Home
- HTCO vs ACRV Comparison
HTCO vs ACRV Comparison
Compare HTCO & ACRV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HTCO
- ACRV
- Stock Information
- Founded
- HTCO 2022
- ACRV 2018
- Country
- HTCO Singapore
- ACRV United States
- Employees
- HTCO N/A
- ACRV N/A
- Industry
- HTCO
- ACRV Medicinal Chemicals and Botanical Products
- Sector
- HTCO
- ACRV Health Care
- Exchange
- HTCO NYSE
- ACRV Nasdaq
- Market Cap
- HTCO 38.7M
- ACRV 36.1M
- IPO Year
- HTCO N/A
- ACRV 2022
- Fundamental
- Price
- HTCO $0.27
- ACRV $1.05
- Analyst Decision
- HTCO
- ACRV Buy
- Analyst Count
- HTCO 0
- ACRV 7
- Target Price
- HTCO N/A
- ACRV $17.60
- AVG Volume (30 Days)
- HTCO 2.1M
- ACRV 728.6K
- Earning Date
- HTCO 01-01-0001
- ACRV 05-14-2025
- Dividend Yield
- HTCO N/A
- ACRV N/A
- EPS Growth
- HTCO N/A
- ACRV N/A
- EPS
- HTCO N/A
- ACRV N/A
- Revenue
- HTCO $108,176,683.00
- ACRV N/A
- Revenue This Year
- HTCO N/A
- ACRV N/A
- Revenue Next Year
- HTCO N/A
- ACRV N/A
- P/E Ratio
- HTCO N/A
- ACRV N/A
- Revenue Growth
- HTCO 13.56
- ACRV N/A
- 52 Week Low
- HTCO $0.21
- ACRV $1.05
- 52 Week High
- HTCO $4.50
- ACRV $10.16
- Technical
- Relative Strength Index (RSI)
- HTCO N/A
- ACRV 31.03
- Support Level
- HTCO N/A
- ACRV $1.06
- Resistance Level
- HTCO N/A
- ACRV $1.19
- Average True Range (ATR)
- HTCO 0.00
- ACRV 0.09
- MACD
- HTCO 0.00
- ACRV 0.05
- Stochastic Oscillator
- HTCO 0.00
- ACRV 0.00
About HTCO CARAVELLE INTERNATIONAL GROUP
High-Trend International Group formerly Caravelle International Group is an international operator of ocean transportation services. It is engaged in the seaborne transportation service under voyage contracts as well as vessel service for and on behalf of ship owners. The company has two operating segments namely, ocean transport and Heating business. The company derives the majority of its revenue from the Ocean transportation business. The company derives freight revenue from voyage contracts and provides vessel service. Majority of revenue is from providing shipping services for customers in Asia, principally in Singapore, Dubai, Korea, Japan, and India.
About ACRV Acrivon Therapeutics Inc.
Acrivon Therapeutics Inc is a clinical-stage biopharmaceutical company developing oncology medicines that the Firm matches to patients whose tumors are predicted to be sensitive to each specific medicine by utilizing its proteomics-based patient responder identification platform. The company's pipeline includes the Phase 2 lead program, ACR-368, referred to as prexasertib, a targeted oncology asset, as well as preclinical stage pipeline programs targeting critical nodes in the DNA Damage Response and cell cycle regulation pathways, including WEE1, a protein kinase, and PKMYT1, a closely related protein serine/threonine kinase.